Rare diseases
Investigational molecules
Locations
Back to Poland827 clinical trials in Poniatowa, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease
PolandPhase 3 Study of Orelabrutinib with Rituximab and Bendamustine vs. Rituximab and Bendamustine in Treatment‑Naïve Mantle Cell Lymphoma Patients
PolandEfficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma
PolandStudy of nivolumab plus drug combination versus standard first-line therapy in patients with advanced Hodgkin lymphoma
PolandStudy of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive
PolandLong‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study
PolandPumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
PolandAUR200 for Patients with Generalized Myasthenia Gravis
PolandRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
PolandA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
PolandComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
PolandLong-Term Study of Imeroprubart in Adults With Graves' Disease
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on hyperlipidemia management, specifically targeting patients at high and very high cardiovascular risk. The research evaluates the effectiveness of rosuvastatin treatments and combination therapies in achieving optimal LDL-C reduction.
These studies aim to establish more effective treatment protocols for patients requiring intensive lipid-lowering therapy.
Comprehensive research evaluating biosimilar treatments for rheumatoid arthritis. The trials compare the efficacy of new biosimilar options with established treatments, focusing on patients with moderate to severe disease conditions.
This research aims to expand treatment options while maintaining high efficacy standards in rheumatoid arthritis management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
